Bridging The Gap: How Process Knowledge Moves From Lab To Launch
The transition of a therapeutic candidate from the research laboratory to full-scale commercial manufacturing is one of the most fragile and expensive phases in the life sciences pipeline. Historically managed through disconnected spreadsheets, word documents, and paper-heavy tech transfer protocols, critical process knowledge frequently becomes siloed across departmental boundaries. This fragmentation introduces significant risks for transcription errors, data integrity gaps, and extended multi-month deployment delays that directly impact clinical windows.
Overcoming these operational bottlenecks requires treating process knowledge as a unified data and systems challenge rather than a process discipline problem. Leveraging modern industrial data fabrics allows organizations to establish a validated, governed architecture that automatically harmonizes data across operations technology (OT) and quality systems. This digital continuity eliminates the need for manual second-person verifications, allowing parameter updates and tech transfers to be executed accurately in minutes rather than weeks.
To explore strategies for optimizing your lifecycle manufacturing intelligence, watch the full discussion here.
Get unlimited access to:
Enter your credentials below to log in. Not yet a member of Bioprocess Online? Subscribe today.